(4-018) Dupilumab Reduces the Risk of Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: Results from BOREAS and NOTUS

Monday, December 8, 2025

2:00 PM - 3:30 PM

Location: Bayside A, Level 1

Co-Author(s): Surya P. Bhatt, Imran Satia, Mena Soliman, Mona Bafadhel

Primary Author(s)

Jigna Heble

Senior Global Medical Director COPD Global Medical Asthma - COPD
Sanofi